Skip to content
B
BiotechEdge
Start 14-Day Free Trial

89bio + Roche

closed

$ETNB acquired by Roche for $3.5B

Deal Summary

Deal Value
$3.5B
Price/Share
$14.5
Announced
Sep 17, 2025
Closed
Oct 30, 2025

Fund Positioning

5 of 20 tracked specialist biotech funds held $ETNB — based on SEC 13F filings.

FundSharesValueEntryAt Announcement
RA Capital Management19.9M$292.4MMar 2025Yes
Avoro Capital Advisors6.4M$93.9MMar 2025Yes
Redmile Group1.5M$21.7MMar 2025Yes
RTW Investments2.0M$19.3MMar 2025Yes
Rock Springs Capital40K$0.4MMar 2025Yes
← All biotech acquisitions